Literature DB >> 7628872

Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin.

S Toyokuni1, T Mori, H Hiai, M Dizdaroglu.   

Abstract

Ferric nitrilotriacetate (Fe-NTA) induces renal proximal tubular damage associated with lipid peroxidation and oxidative DNA base modifications that finally leads to a high incidence of renal adenocarcinoma in rodents. In the present study, we report on the in vivo formation of DNA-protein cross-links (DPCs) involving thymine and tyrosine in the renal chromatin of Wistar rats treated with single or repeated i.p. administration of Fe-NTA. Analyses of chromatin samples by gas chromatography/mass spectrometry revealed a significant increase in the amount of 3-[(1,3-dihydro-2,4-dioxopyrimidin-5-yl)-methyl]-L-tyrosine (Thy-Tyr cross-link) 24 and 48 hr after the administration of Fe-NTA. At 19th day of Fe-NTA treatment, the amount of Thy-Tyr cross-link decreased to the control level, indicating the presence of cellular repair activity. Thy-Tyr cross-link may play a role in the genetic alteration of this renal carcinogenesis model, since mitoses for regeneration of renal proximal tubules were closely associated with the increase in DPCs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628872     DOI: 10.1002/ijc.2910620313

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  RNA oxidation catalyzed by cytochrome c leads to its depurination and cross-linking, which may facilitate cytochrome c release from mitochondria.

Authors:  Mikiei Tanaka; Pawel Jaruga; Pascal A Küpfer; Christian J Leumann; Miral Dizdaroglu; William E Sonntag; P Boon Chock
Journal:  Free Radic Biol Med       Date:  2012-06-07       Impact factor: 7.376

2.  Incision of DNA-protein crosslinks by UvrABC nuclease suggests a potential repair pathway involving nucleotide excision repair.

Authors:  Irina G Minko; Yue Zou; R Stephen Lloyd
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

3.  Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress.

Authors:  T Tanaka; S Kondo; Y Iwasa; H Hiai; S Toyokuni
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 4.  Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis.

Authors:  Shinya Toyokuni
Journal:  Redox Rep       Date:  2013-11-20       Impact factor: 4.412

5.  Chronic unpredictable stress exacerbates 7,12-dimethylbenz (a) anthracene induced hepatotoxicity and nephrotoxicity in Swiss albino mice.

Authors:  Nida Suhail; Nayeem Bilal; Shirin Hasan; Naheed Banu
Journal:  Mol Cell Biochem       Date:  2011-05-01       Impact factor: 3.396

6.  Effect of habitual exercise on renal carcinogenesis by ferric nitrilotriacetate.

Authors:  Toyohiro Kato; Hiroaki Kawaguchi; Noriaki Miyoshi; Kohji Aoyama; Masaharu Komatsu; Masahisa Horiuchi; Hiroki Yoshida; Toru Takeuchi
Journal:  Environ Health Prev Med       Date:  2010-11-25       Impact factor: 3.674

7.  Dietary supplementation of silymarin protects against chemically induced nephrotoxicity, inflammation and renal tumor promotion response.

Authors:  Gurpreet Kaur; Mohammad Athar; M Sarwar Alam
Journal:  Invest New Drugs       Date:  2009-07-10       Impact factor: 3.850

8.  Curcumin attenuates oxidative damage in animals treated with a renal carcinogen, ferric nitrilotriacetate (Fe-NTA): implications for cancer prevention.

Authors:  Mohammad Iqbal; Yasumasa Okazaki; Shigeru Okada
Journal:  Mol Cell Biochem       Date:  2009-01-23       Impact factor: 3.396

Review 9.  Iron and thiols as two major players in carcinogenesis: friends or foes?

Authors:  Shinya Toyokuni
Journal:  Front Pharmacol       Date:  2014-08-28       Impact factor: 5.810

10.  Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes.

Authors:  S Toyokuni; K Okada; S Kondo; H Nishioka; T Tanaka; Y Nishiyama; O Hino; H Hiai
Journal:  Jpn J Cancer Res       Date:  1998-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.